On November 6th, the Trump administration reached an agreement with Novo Nordisk and Eli Lilly to substantially lower the cost of key GLP-1 medications, such as Wegovy and Zepbound, for millions, including Medicare recipients
It is to choose tests based on medical history, diabetes status, other medications, symptoms, dose changes, nutritional intake, and previous results
What to Tell Your Healthcare Provider If youre experiencing persistent lumps, rash, or redness after a GLP-1 injection or if theyre simply becoming bothersome contact your healthcare provider
GLP-1 medications require ongoing injections (except oral semaglutide) and can be expensive
Your provider may recommend slowing your dose escalation, spacing injections differently, or switching to oral semaglutide if injectable cold sensitivity is severe